Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan

INTRODUCTION: The median survival time of patients with advanced soft tissue sarcoma (STS) is typically <12 months. Since 2012, physicians were able to administer second- and/or third-line treatment easily in Japan, following the approval of new drugs, namely, pazopanib, eribulin, and trabectedin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Drug Des Devel Ther
Huvudupphovsmän: Nakamura, Tomoki, Asanuma, Kunihiro, Hagi, Tomohito, Sudo, Akihiro
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7567542/
https://ncbi.nlm.nih.gov/pubmed/33116409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S275526
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk